Symrise: Strong H1 2026 growth, robust cash flow, and strategic transformation drive positive outlook
Symrise: Organic sales growth and strong cash flow offset margin headwinds, supporting 2026 guidance
Symrise publishes H1 2026 interim group report, audit review finds no material misstatements
Symrise H1 FY26 adjusted EBITDA rises to €553 million; sales total €2.54 billion
Symrise signs put option to buy natural fragrance ingredients maker Floral Concept
J.P. Morgan Remains a Buy on Symrise (0G6T)